5-Bromo-4-methoxy-2-methylbenzoic acid
- CAS No.875245-69-5
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity 5-Bromo-4-methoxy-2-methylbenzoic acid (CAS 875245-69-5) designed for pharmaceutical synthesis. Ideal intermediate for Luseogliflozin production with ≥98% purity and global supply capabilities.
Request Bulk PricingProduct Technical Details
Product Overview
5-Bromo-4-methoxy-2-methylbenzoic acid is a highly specialized organic compound serving as a critical building block in modern pharmaceutical manufacturing. This benzoic acid derivative is characterized by its specific substitution pattern, featuring bromo, methoxy, and methyl functional groups that enable precise chemical transformations. Our facility produces this intermediate under strict quality control standards to ensure consistency and reliability for downstream synthesis processes.
As a key precursor in the production of advanced therapeutic agents, this chemical plays an vital role in the synthesis of SGLT2 inhibitors. The molecular structure provides the necessary reactivity for coupling reactions while maintaining stability during storage and handling. We prioritize safety and compliance in all production stages, ensuring that every batch meets international regulatory requirements for pharmaceutical intermediates.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 5-Bromo-4-methoxy-2-methylbenzoic acid |
| CAS Number | 875245-69-5 |
| Molecular Formula | C9H9BrO3 |
| Molecular Weight | 245.073 g/mol |
| Purity | ≥98.0% |
| Appearance | White powder |
| Packaging | 25 kg/drum or customized |
Industrial Applications
The primary application of 5-Bromo-4-methoxy-2-methylbenzoic acid lies in the pharmaceutical sector, specifically as an intermediate for Luseogliflozin synthesis. This compound facilitates the construction of complex molecular architectures required for antidiabetic medications. Its high purity level ensures minimal impurity carryover into final active pharmaceutical ingredients, thereby reducing purification costs and improving overall yield.
Beyond its specific use in SGLT2 inhibitor production, this benzoic acid derivative serves as a versatile synthon in organic chemistry laboratories. Researchers utilize its unique substitution pattern to explore new reaction pathways and develop novel therapeutic candidates. The stability of the bromo and methoxy groups allows for diverse functionalization strategies, making it a valuable asset in medicinal chemistry programs.
Quality Assurance and Logistics
We implement a comprehensive quality management system to guarantee product integrity. Each batch undergoes rigorous testing using high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. Certificates of Analysis (COA) are provided with every shipment, detailing purity levels and impurity profiles. Our commitment to transparency ensures that clients receive full documentation for regulatory submissions.
Logistics and storage are managed with precision to maintain product stability. The material should be stored in a cool, ventilated place away from direct sunlight and moisture. We offer flexible packaging options, including standard 25 kg drums or custom configurations based on client requirements. Global shipping capabilities ensure timely delivery to manufacturing sites worldwide, supported by robust supply chain management.
Compliance and Safety
Our production processes adhere to strict environmental and safety regulations. We do not offer patented products to countries covered by existing patents, ensuring full legal compliance. Customers are advised to verify local regulatory status before procurement. By choosing our facility, partners gain access to a reliable source of high-quality intermediates backed by decades of chemical manufacturing expertise.
